Hypertrophic cardiomyopathy trials in Spain
4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy
- Where
- A Coruña, Alicante, Barcelona, Granada, L'hospitalet De Llobregat, Madrid, Majadahonda, Murcia, Palma, Salamanca, Sevilla, Valencia, Vigo
- Age
- 18 years and over
- People
- 130 worldwide
- Run by
- Imbria Pharmaceuticals Inc.
See details and how to join2024-515125-28-00 · EU 2024-515125-28-00 - Phase 2Taking peopleA Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Where
- A Coruña, Barcelona, El Palmar, Granada, Madrid, Palma de Mallorca, Salamanca, Seville, Valencia, Vigo
- Age
- 18 years and over
- People
- 165 worldwide
- Run by
- Imbria Pharmaceuticals, Inc.
See details and how to joinNCT07023614 - Phase 2/3Enrolling by invitationOpen-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
- Where
- A Coruña, Barcelona, Madrid, Majadahonda, Málaga, Murcia, Palma, Salamanca, Sevilla, Vigo
- Age
- 18 years to 85 years
- People
- 900 worldwide
- Run by
- Cytokinetics
See details and how to joinNCT04848506 · EU 2023-508963-58-00 - No phaseTaking peopleA Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Where
- Burgos, El Palmar, Madrid, Majadahonda, Málaga, Oviedo, Palma de Mallorca
- Age
- 18 years and over
- People
- 1,700 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05489705